Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mathieu Vinken, Peggy Papeleu, Sarah Snykers, Evelien De Rop, Tom Henkens, James Kevin Chipman, Vera Rogiers & Tamara Vanhaecke. (2006) Involvement of Cell Junctions in Hepatocyte Culture Functionality. Critical Reviews in Toxicology 36:4, pages 299-318.
Read now
Read now
Articles from other publishers (49)
Aikaterini Giannopoulou, Athanassios Velentzas, Eumorphia Konstantakou, Margaritis Avgeris, Stamatia Katarachia, Nikos Papandreou, Nikolas Kalavros, Vassiliki Mpakou, Vassiliki Iconomidou, Ema Anastasiadou, Ioannis Kostakis, Issidora Papassideri, Gerassimos Voutsinas, Andreas Scorilas & Dimitrios Stravopodis. (2019) Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer. International Journal of Molecular Sciences 20:6, pages 1291.
Crossref
Crossref
Diamantis I. Tsilimigras, Ioannis Ntanasis-Stathopoulos, Demetrios Moris, Eleftherios Spartalis & Timothy M. Pawlik. (2018) Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective. Surgical Oncology 27:4, pages 611-618.
Crossref
Crossref
Masumeh Sanaei, Fraidoon Kavoosi, Abazar Roustazadeh & Fatemeh Golestan. (2018) Effect of Genistein in Comparison with Trichostatin A on Reactivation of DNMTs Genes in Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology 6:2, pages 1-6.
Crossref
Crossref
Maha S. Al-Keilani & Nour A. Al-Sawalha. (2017) Potential of Phenylbutyrate as Adjuvant Chemotherapy: An Overview of Cellular and Molecular Anticancer Mechanisms. Chemical Research in Toxicology 30:10, pages 1767-1777.
Crossref
Crossref
Michaël Maes, Sara Crespo Yanguas, Joost Willebrords & Mathieu Vinken. (2015) Models and methods for in vitro testing of hepatic gap junctional communication. Toxicology in Vitro 30:1, pages 569-577.
Crossref
Crossref
Rosaria Benedetti, Mariarosaria Conte, Concetta Iside & Lucia Altucci. (2015) Epigenetic-based therapy: From single- to multi-target approaches. The International Journal of Biochemistry & Cell Biology 69, pages 121-131.
Crossref
Crossref
Lisa Lange, Peter Hemmerich & Birgit Spänkuch. (2015) Survival of primary, but not of cancer cells after combined Plk1-HDAC inhibition. Oncotarget 6:28, pages 25801-25814.
Crossref
Crossref
Anderly C. ChuehJanson W.T. TseLars TögelJohn M. Mariadason. (2015) Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells. Antioxidants & Redox Signaling 23:1, pages 66-84.
Crossref
Crossref
M. Lemper, S. Snykers, T. Vanhaecke, K. De Paepe & V. Rogiers. (2014) Current Status of Healthy Human Skin Models: Can Histone Deacetylase Inhibitors Potentially Improve the Present Replacement Models?. Skin Pharmacology and Physiology 27:1, pages 36-46.
Crossref
Crossref
Catheleyne D'hondt, Jegan Iyyathurai, Mathieu Vinken, Vera Rogiers, Luc Leybaert, Bernard Himpens & Geert Bultynck. (2013) Regulation of connexin- and pannexin-based channels by post-translational modifications. Biology of the Cell 105:9, pages 373-398.
Crossref
Crossref
Yuqing Liu, Zhuo Wang, Jianing Wang, Wingchi Lam, Shuqin Kwong, Furong Li, Scott L. Friedman, Shuyan Zhou, Qi Ren, Zhengshuang Xu, XinGen Wang, Ling Ji, Shoubin Tang, Hui Zhang, Eric L. Lui & Tao Ye. (2012) A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor‐β and vascular endothelial growth factor signalling. Liver International 33:4, pages 504-515.
Crossref
Crossref
T Wunder, K Schmid, D Wicklein, P Groitl, T Dobner, T Lange, M Anders & U Schumacher. (2012) Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infection. Cancer Gene Therapy 20:1, pages 25-32.
Crossref
Crossref
Joanna Edyta Fraczek, Mathieu Vinken, Dirk Tourwé, Tamara Vanhaecke & Vera Rogiers. (2011) Synergetic effects of DNA demethylation and histone deacetylase inhibition in primary rat hepatocytes. Investigational New Drugs 30:4, pages 1715-1724.
Crossref
Crossref
Ki-Eun Joung, Kyung-Nan Min, Dae-Kee Kim & Yhun-Yhong Sheen. (2012) Anti-Cancer Effect of IN-2001 in T47D Human Breast Cancer. Biomolecules and Therapeutics 20:1, pages 81-88.
Crossref
Crossref
Karen M VanderMolen, William McCulloch, Cedric J Pearce & Nicholas H Oberlies. (2011) Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma. The Journal of Antibiotics 64:8, pages 525-531.
Crossref
Crossref
Zacharoula Konsoula, Hong Cao, Alfredo Velena & Mira Jung. (2011) Adamantanyl-Histone Deacetylase Inhibitor H6CAHA Exhibits Favorable Pharmacokinetics and Augments Prostate Cancer Radiation Sensitivity. International Journal of Radiation Oncology*Biology*Physics 79:5, pages 1541-1548.
Crossref
Crossref
Cheol Yong Yoon, Mi Jung Park, Jung Sun Lee, Sang Chul Lee, Jong Jin Oh, Hongzoo Park, Chang Wook Chung, Murod M. Abdullajanov, Seong Jin Jeong, Sung Kyu Hong, Seok Soo Byun, Eun Sik Lee & Sang Eun Lee. (2011) The Histone Deacetylase Inhibitor Trichostatin A Synergistically Resensitizes a Cisplatin Resistant Human Bladder Cancer Cell Line. Journal of Urology 185:3, pages 1102-1111.
Crossref
Crossref
Mathieu Vinken. (2011) Role of connexin-related signalling in hepatic homeostasis and its relevance for liver-based in vitro modelling. World Journal of Gastrointestinal Pathophysiology 2:5, pages 82.
Crossref
Crossref
Zacharoula Konsoula, Alfredo Velena, Rachel Lee, Anatoly Dritschilo & Mira Jung. 2012. Human Cell Transformation. Human Cell Transformation
171
179
.
Jiahuai Tan, Shundong Cang, Yuehua Ma, Richard L Petrillo & Delong Liu. (2010) Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. Journal of Hematology & Oncology 3:1.
Crossref
Crossref
Jan C. Purrucker & Ulrich Mahlknecht. (2010) Targeting the epigenome: effects of epigenetic treatment strategies on genomic stability in healthy human cells. Clinical Epigenetics 1:1-2, pages 45-54.
Crossref
Crossref
Ilya Freidkin, Michal Herman, Ana Tobar, Avry Chagnac, Yaacov Ori, Asher Korzets & Uzi Gafter. (2010) Effects of histone deacetylase inhibitors on rat mesangial cells. American Journal of Physiology-Renal Physiology 298:2, pages F426-F434.
Crossref
Crossref
Ke Long JinJeong-Yeol ParkEun Joo NohKwang Lae HoeJoo Hak LeeJong-Hyeok KimJoo-Hyun Nam. (2010) The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells. Journal of Gynecologic Oncology 21:4, pages 262.
Crossref
Crossref
Xiaoli Ma, Quanfu Ma, Jia Liu, Yuan Tian, Beibei Wang, Kathryn M. Taylor, Peng Wu, Daowen Wang, Gang Xu, Li Meng, Shixuan Wang, Ding Ma & Jianfeng Zhou. (2009)
Identification of
LIV1
, a Putative Zinc Transporter Gene Responsible for HDACi-Induced Apoptosis, Using a Functional Gene Screen Approach
. Molecular Cancer Therapeutics 8:11, pages 3108-3116.
Crossref
Crossref
Rose-Marie Catalioto, Carlo Alberto Maggi & Sandro Giuliani. (2009) Chemically distinct HDAC inhibitors prevent adipose conversion of subcutaneous human white preadipocytes at an early stage of the differentiation program. Experimental Cell Research 315:19, pages 3267-3280.
Crossref
Crossref
Y.-L. Chung, M.-Y. Lee & N. N.M. Pui. (2009) Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis. Carcinogenesis 30:8, pages 1387-1397.
Crossref
Crossref
Joanna Fraczek, Sarah Deleu, Aneta Lukaszuk, Tatyana Doktorova, Dirk Tourwé, Albert Geerts, Tamara Vanhaecke, Karin Vanderkerken & Vera Rogiers. (2008) Screening of amide analogues of Trichostatin A in cultures of primary rat hepatocytes: search for potent and safe HDAC inhibitors. Investigational New Drugs 27:4, pages 338-346.
Crossref
Crossref
Sarah Snykers, Tom Henkens, Evelien De Rop, Mathieu Vinken, Joanna Fraczek, Joery De Kock, Evi De Prins, Albert Geerts, Vera Rogiers & Tamara Vanhaecke. (2009) Role of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation. Journal of Hepatology 51:1, pages 187-211.
Crossref
Crossref
Hossein Hemmatazad, Hanna Maciejewska Rodrigues, Britta Maurer, Fabia Brentano, Margarita Pileckyte, Jörg H. W. Distler, Renate E. Gay, Beat A. Michel, Steffen Gay, Lars C. Huber, Oliver Distler & Astrid Jüngel. (2009) Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. Arthritis & Rheumatism 60:5, pages 1519-1529.
Crossref
Crossref
Sarah Snykers, Joery De Kock, Vera Rogiers & Tamara Vanhaecke. (2009) In Vitro Differentiation of Embryonic and Adult Stem Cells into Hepatocytes: State of the Art. Stem Cells 27:3, pages 577-605.
Crossref
Crossref
S.-T. Lee, T.-T. Wu, P.-Y. Yu & R.-M. Chen. (2009) Apoptotic insults to human HepG2 cells induced by S-(+)-ketamine occurs through activation of a Bax-mitochondria-caspase protease pathway. British Journal of Anaesthesia 102:1, pages 80-89.
Crossref
Crossref
William C. Kisseberth, Sridhar Murahari, Cheryl A. London, Samuel K. Kulp & Ching-Shih Chen. (2008) Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines. American Journal of Veterinary Research 69:7, pages 938-945.
Crossref
Crossref
Tom Henkens, Mathieu Vinken, Aneta Lukaszuk, Dirk Tourwé, Tamara Vanhaecke & Vera Rogiers. (2008) Differential effects of hydroxamate histone deacetylase inhibitors on cellular functionality and gap junctions in primary cultures of mitogen-stimulated hepatocytes. Toxicology Letters 178:1, pages 37-43.
Crossref
Crossref
Ruey-Chyi Su, Allan B. Becker, Anita L. Kozyrskyj & Kent T. HayGlass. (2008) Epigenetic regulation of established human type 1 versus type 2 cytokine responses. Journal of Allergy and Clinical Immunology 121:1, pages 57-63.e3.
Crossref
Crossref
Roya Khosravi-Far & Eileen WhiteSharmila Shankar & Rakesh K. Srivastava. 2008. Programmed Cell Death in Cancer Progression and Therapy. Programmed Cell Death in Cancer Progression and Therapy
261
298
.
P. Papeleu, A. Wullaert, G. Elaut, T. Henkens, M. Vinken, G. Laus, D. Tourwé, R. Beyaert, V. Rogiers & T. Vanhaecke. (2007)
Inhibition of NF-?B activation by the histone deacetylase inhibitor 4-Me
2
N-BAVAH induces an early G
1
cell cycle arrest in primary hepatocytes
. Cell Proliferation 40:5, pages 640-655.
Crossref
Crossref
Won-Jun Lee. (2007) Effects of Histone Deacetylase Inhibitor, Trichostatin A, on the Differentiation of C2C12 Myoblasts and the Expression of Cell Cycle Regulators. Journal of Life Science 17:7, pages 976-982.
Crossref
Crossref
Sarah Snykers, Mathieu Vinken, Vera Rogiers & Tamara Vanhaecke. (2007) Differential role of epigenetic modulators in malignant and normal stem cells: a novel tool in preclinical in vitro toxicology and clinical therapy. Archives of Toxicology 81:8, pages 533-544.
Crossref
Crossref
Mathieu Vinken, Tom Henkens, Sarah Snykers, Aneta Lukaszuk, Dirk Tourwé, Vera Rogiers & Tamara Vanhaecke. (2007) The novel histone deacetylase inhibitor 4-Me2N-BAVAH differentially affects cell junctions between primary hepatocytes. Toxicology 236:1-2, pages 92-102.
Crossref
Crossref
Sarah Snykers, Tamara Vanhaecke, Ann De Becker, Peggy Papeleu, Mathieu Vinken, Ivan Van Riet & Vera Rogiers. (2007) Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow. BMC Developmental Biology 7:1.
Crossref
Crossref
L. David Wise, Katie J. Turner & Janet S. Kerr. (2007) Assessment of developmental toxicity of vorinostat, a histone deacetylase inhibitor, in Sprague‐Dawley rats and Dutch Belted rabbits. Birth Defects Research Part B: Developmental and Reproductive Toxicology 80:1, pages 57-68.
Crossref
Crossref
Nichole Boyer Arnold, Nohea Arkus, Jason Gunn & Murray Korc. (2007) The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Induces Growth Inhibition and Enhances Gemcitabine-Induced Cell Death in Pancreatic Cancer. Clinical Cancer Research 13:1, pages 18-26.
Crossref
Crossref
Sharmila Shankar & Rakesh K. Srivastava. 2007. Apoptosis, Cell Signaling, and Human Diseases. Apoptosis, Cell Signaling, and Human Diseases
335
361
.
Srinivasa-Gopalan Sampathkumar, Mark B. Jones, M. Adam Meledeo, Christopher T. Campbell, Sean S. Choi, Kaoru Hida, Prasra Gomutputra, Anthony Sheh, Tim Gilmartin, Steven R. Head & Kevin J. Yarema. (2006) Targeting Glycosylation Pathways and the Cell Cycle: Sugar-Dependent Activity of Butyrate-Carbohydrate Cancer Prodrugs. Chemistry & Biology 13:12, pages 1265-1275.
Crossref
Crossref
Mathieu Vinken, Tom Henkens, Tamara Vanhaecke, Peggy Papeleu, Albert Geerts, Elke Van Rossen, James Kevin Chipman, Paolo Meda & Vera Rogiers. (2006) Trichostatin A Enhances Gap Junctional Intercellular Communication in Primary Cultures of Adult Rat Hepatocytes. Toxicological Sciences 91:2, pages 484-492.
Crossref
Crossref
Mathieu Vinken, Tamara Vanhaecke, Peggy Papeleu, Sarah Snykers, Tom Henkens & Vera Rogiers. (2006) Connexins and their channels in cell growth and cell death. Cellular Signalling 18:5, pages 592-600.
Crossref
Crossref
Sandra Coecke, Hans Ahr, Bas J. Blaauboer, Susanne Bremer, Silvia Casati, Josè Castell, Robert Combes, Raffaella Corvi, Charles L. Crespi, Michael L. Cunningham, Greetje Elaut, Brighitta Eletti, Andreas Freidig, Alessandra Gennari, Jean-François Ghersi-Egea, Andre Guillouzo, Thomas Hartung, Peter Hoet, Magnus Ingelman-Sundberg, Sharon Munn, Walter Janssens, Bernhard Ladstetter, David Leahy, Anthony Long, Annarita Meneguz, Mario Monshouwer, Siegfried Morath, Fred Nagelkerke, Olavi Pelkonen, Jessica Ponti, Pilar Prieto, Lysianne Richert, Enrico Sabbioni, Beatrice Schaack, Winfried Steiling, Emanuela Testai, Joan-Albert Vericat & Andrew Worth. (2019)
Metabolism: A Bottleneck in
In Vitro
Toxicological Test Development
. Alternatives to Laboratory Animals 34:1, pages 49-84.
Crossref
Crossref
Takahiko Ogawa, Tomonori Hayashi, Masahide Tokunou, Kei Nakachi, James E. Trosko, Chia-Cheng Chang & Noriaki Yorioka. (2005)
Suberoylanilide Hydroxamic Acid Enhances Gap Junctional Intercellular Communication via Acetylation of Histone Containing
Connexin 43
Gene Locus
. Cancer Research 65:21, pages 9771-9778.
Crossref
Crossref
. (2005) Modulacon of Cell Cycle Control by Histone Deacetylase Inhibitor Trichostatin A in A549 Human Non-small Cell Lung Cancer Cells. Journal of Life Science 15:5, pages 726-733.
Crossref
Crossref